Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Business & Regulation Business Practice

Man Allegedly Praises Pharmaceutical Companies...

The man in question? Joe Biden – well known for speaking up against drug prices in the US. The headline that actually appeared in my news feed? “Joe Biden Reportedly Praises Pharmaceutical Companies.” Other media outlets ran with similar headlines, seemingly unable to resist taking a pop at Biden and pharma in one go. It must have been a slow news day.

Biden apparently dared say there were “great drug companies out there – except for a couple of opioid outfits.” Some have criticized Biden for praising companies that are “greedy, corrupt, and engaged in price fixing.” (1, 2) 

A new Gallup poll claims that, in the USA, big pharma is viewed with more distaste than any other industry (3). Even the Federal government has a better reputation than the drug industry. The high-profile situation with opioids will not have helped the industry’s image (look forward to an in-depth report on opioids in the November issue of The Medicine Maker). 

We’ve said it before, but pharma must do more to promote the industry’s good side. In a recent conversation with Tony Hitchcock from Cobra Biologics, I was told that pharma’s negative reputation could have a negative effect on attracting talent; young scientists will likely be more attracted to medicine and healthcare rather than drug development. And the pharma industry needs (and deserves) great talent to fuel R&D.

Rather more worryingly, politicians appear to be somewhat ignorant of how the wheels of the pharma industry turn. For example, in late September, Jeremy Corbyn – leader of the UK’s Labour Party – announced that he wants to seize patent rights from companies and establish a state-run operation to produce generic drugs (4). 

We all want improved access to medicines but nothing comes for free. Corbyn’s plans could completely disincentivize drug development. The announcement does, however, highlight the mounting anger and desperation on drug pricing. If pharma itself doesn’t come up with workable solutions quickly (the recent announcement about a vaccines subscription from the NHS is one example of a more intriguing approach to the challenges of drug costs), then drug pricing will continue to feature on political agendas. And proposed solutions could be become even more radical.

Enjoy our FREE content!

Log in or register to gain full unlimited access to all content on the The Medicine Maker site. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

  1. Business Insider, “Joe Biden reportedly praised pharmaceutical companies at a private party despite publicly railing against high drug prices” (2019). Available at https://bit.ly/2lkJkIk. Last accessed September 26, 2019.
  2. Bloomberg, “Biden Praises Pharma to Donors as He Pushes to Cut Prices” (2019). Available at https://bloom.bg/2lUS34c. Last accessed September 26, 2019.
  3. Gallup, “Big Pharma Sinks to the Bottom of U.S. Industry Rankings” (2019). Available at  https://bit.ly/2jUQ3b4. Last accessed September 26, 2019.
  4. BBC News, “Labour on collision course with big pharma over drugs” (2019). Available at https://bbc.in/2lKRn1o. Last accessed September 26, 2019.

About the Author

Stephanie Sutton

Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent seven years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register